Cost-effectiveness of a “treat-all” strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages

por Suenaga, Riichiro, Suka, Machi, Hirao, Tomohiro, Hidaka, Isao, Sakaida, Isao, Ishida, Haku
Publicado 2021